Docket #: S23-057
Hydrogel injection for intestinal lengthening
Stanford scientists have developed a novel approach to help patients with short bowel syndrome by using intestinal lengthening. The solution involves injecting a degradable hydrogel into the intestinal wall to narrow the lumen and enable the confinement of a coiled spring. Currently, no devices are available for deploying inside the intestine to achieve this and existing methods necessitate surgical procedures to anchor the intestinal expanding device. However, as an injectable hydrogel, the solution facilitates endoscopic delivery of the coiled spring into the gastrointestinal tract. While the hydrogel solution enables strategically deploying devices within the gastrointestinal lumen for a transient duration, this approach may also be employed for drugs intended for a particular section of the gastrointestinal tract, anchoring the device near the area of interest instead of opting for systemic delivery.
Applications
- Minimally-invasive method for anchoring intestinal lengthening device (short bowel syndrome)
- Targeted drug delivery in the gastrointestinal tract
Advantages
- Lower need for surgical intervention
- Lower costs required for device placement
- Quicker recovery time
Related Links
Patents
- Published Application: 20240366501
Similar Technologies
-
Injectable Supramolecular Hydrogels for Bioprinting, Wound Healing, and Drug Delivery S20-136Injectable Supramolecular Hydrogels for Bioprinting, Wound Healing, and Drug Delivery
-
Use of Focal Adhesion Kinase Inhibitors To Reduce Scar Formation In Combination With Split Thickness Skin Grafts S21-198Use of Focal Adhesion Kinase Inhibitors To Reduce Scar Formation In Combination With Split Thickness Skin Grafts
-
Hydrogels for precise tumor inoculation in preclinical research S20-389Hydrogels for precise tumor inoculation in preclinical research